181 studies found for:    Open Studies | "Psoriasis"
Show Display Options
Rank Status Study
21 Recruiting BOSTRIP: Biomarkers of Systemic Treatment Response in Psoriasis
Condition: Psoriasis
Intervention: Other: Withdrawal of venous blood samples
22 Unknown  TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis
Condition: Psoriasis
Intervention: Drug: subjects will receive either infliximab, adalimumab or etanercept
23 Recruiting The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis
Condition: Psoriasis
Intervention:
24 Recruiting Reduction of Pain Caused by Biologic Drugs in Psoriasis
Conditions: Psoriasis;   Pain
Interventions: Other: Heating Pack;   Other: Ice pack
25 Unknown  Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients
Conditions: Type 2 Diabetes;   Psoriasis
Intervention: Drug: GLP-1 analog
26 Recruiting Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Conditions: Psoriasis;   Atopic Dermatitis
Interventions: Other: Blood pressure;   Other: Height;   Other: Weight;   Other: BMI;   Other: Waist Circumference
27 Unknown  The Effect of Alga Dunaliella Bardawil on Psoriasis
Condition: Psoriasis
Interventions: Dietary Supplement: Alga Dunaliella Bardawil placebo;   Dietary Supplement: Dunaliella Bardawil
28 Unknown  Determination of the Efficacy and Safety of Psoralait Versus Placebo in the Treatment of Psoriasis
Condition: Psoriasis
Interventions: Other: Psoralait;   Other: Placebo cream.
29 Recruiting Clinical Assessment and Psychosocial Impact of Psoriasis
Condition: Psoriasis
Intervention:
30 Recruiting UVB-311nm After Initial Slow Response to Adalimumab in Psoriasis
Condition: Psoriasis
Interventions: Radiation: UVB-311nm;   Other: No treatment
31 Recruiting Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: Trichuris Suis Ova
32 Recruiting Secukinumab in TNF-IR Psoriasis Patients.
Condition: Psoriasis
Interventions: Biological: Secukinumab 150 mg;   Biological: Secukinumab 300 mg
33 Recruiting A Study of Topical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type Psoriasis
Condition: Psoriasis
Interventions: Drug: Indigo Naturalis;   Drug: Placebo
34 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis
Condition: Psoriasis
Intervention:
35 Recruiting Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis
Conditions: Psoriasis;   Cardiovascular Diseases;   Dyslipidemia
Intervention:
36 Unknown  The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis
Conditions: Psoriasis;   Cardiovascular Diseases;   Diabetes Mellitus, Type 2
Interventions: Drug: Adalimumab treatment arm;   Drug: Fumaric acid esters treatment group;   Other: Narrow band UVB radiation
37 Not yet recruiting ASIS for Enbrel in Plaque Psoriasis
Condition: Plaque Psoriasis.
Interventions: Drug: Gadolinium;   Drug: Efficacy of Enbrel subcutaneously at Week 12;   Drug: Efficacy of Enbrel subcutaneously at Week 24;   Drug: Efficacy of Enbrel subcutaneously at Week 36;   Drug: Efficacy of Enbrel subdermally at Week 12;   Drug: Efficacy of Enbrel subdermally at Week 24;   Drug: Efficacy of Enbrel subdermally at Week 36;   Drug: PASI 75 n(%) subcutaneously at Week 12;   Drug: PASI 75 n(%) subcutaneously at Week 24;   Drug: PASI 75 n(%) subcutaneously at Week 36;   Drug: PASI 75 n(%) subdermally at Week 12;   Drug: PASI 75 n(%) subdermally at Week 24;   Drug: PASI 75 n(%) subdermally at Week 36;   Drug: Adverse Reactions of Enbrel subcutaneously;   Drug: Adverse Reactions of Enbrel subdermally at Week 36
38 Unknown  Cross-sectional Evaluation of Biological Markers of Cardiovascular Disease in Children and Adolescents With Psoriasis
Conditions: Psoriasis;   Obesity;   Cardiovascular Risk;   Inflammation
Intervention:
39 Recruiting A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis
Conditions: Psoriasis;   Nonalcoholic Fatty Liver Disease
Intervention:
40 Unknown  Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis
Condition: Psoriasis
Intervention: Behavioral: Weight Loss

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years